354 related articles for article (PubMed ID: 25912409)
1. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries.
Yoshitomi T; Nagasaki Y
Adv Healthc Mater; 2014 Aug; 3(8):1149-61. PubMed ID: 24482427
[TBL] [Abstract][Full Text] [Related]
3. Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
Biomaterials; 2016 Aug; 99():109-23. PubMed ID: 27235996
[TBL] [Abstract][Full Text] [Related]
4. PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells.
Zeighamian V; Darabi M; Akbarzadeh A; Rahmati-Yamchi M; Zarghami N; Badrzadeh F; Salehi R; Mirakabad FS; Taheri-Anganeh M
Artif Cells Nanomed Biotechnol; 2016; 44(2):735-42. PubMed ID: 25819738
[TBL] [Abstract][Full Text] [Related]
5. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles.
Yoshitomi T; Hirayama A; Nagasaki Y
Biomaterials; 2011 Nov; 32(31):8021-8. PubMed ID: 21816462
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria.
Hilchie AL; Furlong SJ; Sutton K; Richardson A; Robichaud MR; Giacomantonio CA; Ridgway ND; Hoskin DW
Nutr Cancer; 2010; 62(3):379-89. PubMed ID: 20358476
[TBL] [Abstract][Full Text] [Related]
9. Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer.
Yin H; Zhang H; Liu B
Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):634-40. PubMed ID: 23786839
[TBL] [Abstract][Full Text] [Related]
10. Alginate Nanoparticles Containing Curcumin and Resveratrol: Preparation, Characterization, and In Vitro Evaluation Against DU145 Prostate Cancer Cell Line.
Saralkar P; Dash AK
AAPS PharmSciTech; 2017 Oct; 18(7):2814-2823. PubMed ID: 28397161
[TBL] [Abstract][Full Text] [Related]
11. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
12. Enhanced apoptotic effect of curcumin loaded solid lipid nanoparticles.
Vandita K; Shashi B; Santosh KG; Pal KI
Mol Pharm; 2012 Dec; 9(12):3411-21. PubMed ID: 23127155
[TBL] [Abstract][Full Text] [Related]
13. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy.
Jeong D; Bae BC; Park SJ; Na K
J Control Release; 2016 Jan; 222():78-85. PubMed ID: 26686664
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
16. Redox nanoparticle therapeutics to cancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect.
Yoshitomi T; Ozaki Y; Thangavel S; Nagasaki Y
J Control Release; 2013 Nov; 172(1):137-143. PubMed ID: 23958903
[TBL] [Abstract][Full Text] [Related]
17. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.
Mohanty C; Sahoo SK
Biomaterials; 2010 Sep; 31(25):6597-611. PubMed ID: 20553984
[TBL] [Abstract][Full Text] [Related]
18. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticervical cancer activity of novel pH responsive micelles for oral curcumin delivery.
Sajomsang W; Gonil P; Saesoo S; Ruktanonchai UR; Srinuanchai W; Puttipipatkhachorn S
Int J Pharm; 2014 Dec; 477(1-2):261-72. PubMed ID: 25455774
[TBL] [Abstract][Full Text] [Related]
20. Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix Composition.
Djiokeng Paka G; Doggui S; Zaghmi A; Safar R; Dao L; Reisch A; Klymchenko A; Roullin VG; Joubert O; Ramassamy C
Mol Pharm; 2016 Feb; 13(2):391-403. PubMed ID: 26618861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
